Frédéric Stauffer

2.2k citations
24 papers · 1.8k · 1 hit paper · h-index 16

Impact in

  • Genetics top 5%
    • Chronic Lymphocytic Leukemia Research
    • PI3K/AKT/mTOR signaling in cancer
    • Protein Kinase Regulation and GTPase Signaling
    • Epigenetics and DNA Methylation
    • Cancer-related gene regulation
    • Protein Degradation and Inhibitors

Papers in

    • PI3K/AKT/mTOR signaling in cancer 7
    • Cancer-related gene regulation 4
    • Epigenetics and DNA Methylation 3
    • Biochemical and Molecular Research 3
    • Protein Degradation and Inhibitors 2
    • Synthesis and Biological Evaluation 3

Frédéric Stauffer

23 papers receiving 1.8k citations

Frédéric Stauffer's Hit Papers

Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity 2008 · 993 citations
9930+6+12Years since publication250500750

Peers

Frédéric Stauffer
Comparison fields: 5 of 82
  • Genetics 218
  • Molecular Biology 1.4k
  • Pathology and Forensic Medicine 216
  • Oncology 318
  • Cancer Research 169
Replace Michael Zinda with:
Michael Zinda United States
Josef Brueggen Switzerland
Christine Fritsch Switzerland
Jessica Adickes United States
Jay Gibbons United States
Lisa Roberts United States
Katherine G. Moss United States
Nathan T. Ihle United States
Denis Drygin United States
Jung-Sik Kim United States
Frédéric Stauffer relative to Michael Zinda United States Michael Zinda's profile →
Citations per field
00.5×2×3×
Michael Zinda · 1×
Citations per year

Countries citing papers authored by Frédéric Stauffer

Since Specialization
Citations

This map shows the geographic impact of Frédéric Stauffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Stauffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Stauffer more than expected).

Fields of papers citing papers by Frédéric Stauffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Stauffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Stauffer. The network helps show where Frédéric Stauffer may publish in the future.

Co-authors

The 25 scholars most cited alongside Frédéric Stauffer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frédéric Stauffer Line = papers co-authored together Frédéric Stauffer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
Hit paper breakdown →
2008993
2 2008148
3 200994
4 200994
5 200877
6 201653
7 201651
8 201743
9 201639
10 200330
11 201929
12 199728
13 200926
14 201525
15 201523
16 201615
17 200113
18 201212
19 20168
20 20195

About Frédéric Stauffer

Frédéric Stauffer is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Toxicology and Endocrinology, Diabetes and Metabolism, having authored 24 papers that have together received 1.8k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (7 papers), Cancer-related gene regulation (4 papers), Epigenetics and DNA Methylation (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), Bone health and treatments (3 papers), Biochemical and Molecular Research (3 papers), Synthesis and Biological Evaluation (3 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Genetics (218 citations), Molecular Biology (1.4k citations), Pathology and Forensic Medicine (216 citations), Oncology (318 citations) and Cancer Research (169 citations). Frédéric Stauffer has collaborated with scholars based in Switzerland, United States and China. Frequent co-authors include Sauveur-Michel Maira, Christian Schnell, Pascal Furet, Carlos García-Echeverría, Patrick Chêne, Christine Fritsch, Josef Brueggen, Daniela Gabriel, Peter M. Finan and Doriano Fabbro. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, ACS Medicinal Chemistry Letters, Cancer Research, Angewandte Chemie International Edition and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact